Saratoga Health & Biotechnology Fund is a registered fund series of SARATOGA ADVANTAGE TRUST (series S000010884). Net assets $10.5M as of 2026-05-31.
Showing 15 of 29 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| CARDINAL HEALTH INC | — | $675K | 644.17% |
| JAZZ PHARMACEUTICALS PLC | — | $648K | 618.77% |
| UNITED THERAPEUTICS CORP | — | $646K | 616.57% |
| AMGEN INC | — | $528K | 503.77% |
| MCKESSON CORP | — | $513K | 489.72% |
| LANTHEUS HOLDINGS INC | — | $487K | 464.46% |
| EXELIXIS INC | — | $477K | 455.12% |
| NOVARTIS AG | — | $472K | 450.11% |
| CENCORA INC | — | $453K | 432.74% |
| GILEAD SCIENCES INC | — | $412K | 393.69% |
| REGENERON PHARMACEUTICALS INC | — | $412K | 393.19% |
| JOHNSON & JOHNSON | — | $410K | 391.47% |
| NATIONAL HEALTHCARE CORP | — | $389K | 371.80% |
| MERCK & COMPANY INC | — | $381K | 363.32% |
| CIGNA GROUP (THE) | — | $380K | 363.04% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $10.5M |
| 2026-02-28 | $11.6M |
| 2025-11-30 | $11.5M |
| 2025-08-31 | $9.9M |
| 2025-05-31 | $10.1M |
| 2025-02-28 | $10.8M |
| 2024-11-30 | $11.9M |
| 2024-08-31 | $13.2M |